Your browser doesn't support javascript.
loading
Advancing Cardio-Oncology in Asia.
Ng, Choon Ta; Tan, Li Ling; Sohn, Il Suk; Gonzalez Bonilla, Hilda; Oka, Toru; Yinchoncharoen, Teerapat; Chang, Wei-Ting; Chong, Jun Hua; Cruz Tan, Maria Katrina; Cruz, Rochelle Regina; Astuti, Astri; Agarwala, Vivek; Chien, Van; Youn, Jong-Chan; Tong, Jieli; Herrmann, Joerg.
Afiliação
  • Ng CT; Department of Cardiovascular Medicine, Mayo Clinic Rochester, Rochester, MN, USA.
  • Tan LL; Department of Cardiology, National Heart Centre Singapore, Singapore. ng.choon.ta@singhealth.com.sg.
  • Sohn IS; Department of Cardiology, National University Heart Centre Singapore, Singapore.
  • Gonzalez Bonilla H; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Oka T; Department of Cardiology, Kyung Hee University Hospital at Gangdong, Seoul, Korea.
  • Yinchoncharoen T; Department of Cardiovascular Medicine, Mayo Clinic Rochester, Rochester, MN, USA.
  • Chang WT; Onco-Cardiology Unit, Department of Internal Medicine, Saitama Cancer Center, Saitama, Japan.
  • Chong JH; Department of Cardiology, Ramathibodi Hospital, Bangkok, Thailand.
  • Cruz Tan MK; Division of Cardiology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan.
  • Cruz RR; Department of Cardiology, National Heart Centre Singapore, Singapore.
  • Astuti A; Department of Cardiology, St. Luke's Medical Center, Quezon, The Philippines.
  • Agarwala V; Department of Cardiology, Cardinal Santos Medical Center, Metro Manila, The Philippines.
  • Chien V; Department of Cardiology and Vascular Medicine, Hasan Sadikin General Hospital, Bandung, Indonesia.
  • Youn JC; Department of Medical Oncology and Haemato-Oncology, Narayana Superspeciality Hospital and Cancer Institute, Howrah, India.
  • Tong J; Department of Cardiology, National Heart Institute, Hanoi, Vietnam.
  • Herrmann J; Seoul St. Mary's Hospital, Catholic Research Institute for Intractable Cardiovascular Disease, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Korean Circ J ; 53(2): 69-91, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36792558
ABSTRACT
Cardio-oncology is an emerging multi-disciplinary field, which aims to reduce morbidity and mortality of cancer patients by preventing and managing cancer treatment-related cardiovascular toxicities. With the exponential growth in cancer and cardiovascular diseases in Asia, there is an emerging need for cardio-oncology awareness among physicians and country-specific cardio-oncology initiatives. In this state-of-the-art review, we sought to describe the burden of cancer and cardiovascular disease in Asia, a region with rich cultural and socio-economic diversity. From describing the uniqueness and challenges (such as socio-economic disparity, ethnical and racial diversity, and limited training opportunities) in establishing cardio-oncology in Asia, and outlining ways to overcome any barriers, this article aims to help advance the field of cardio-oncology in Asia.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Korean Circ J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Korean Circ J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos